Company profile for AgenTus Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AgenTus Therapeutics was formed in 2017 as a subsidiary of Agenus Inc. to accelerate development of allogeneic adoptive cell therapies. Today we are more than 25 employees working across the U.S. and the U.K. Our expert scientists are working with world leading academic and commercial institutions to pioneer the delivery of living drugs to change lives of cancer patients. AgenTus Therapeutics is focused on the discovery, de...
AgenTus Therapeutics was formed in 2017 as a subsidiary of Agenus Inc. to accelerate development of allogeneic adoptive cell therapies. Today we are more than 25 employees working across the U.S. and the U.K. Our expert scientists are working with world leading academic and commercial institutions to pioneer the delivery of living drugs to change lives of cancer patients. AgenTus Therapeutics is focused on the discovery, development, and commercialization of breakthrough “living drugs” to advance cures for cancer patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Cambridge Science Park Milton Road Cambridge
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty